Carroll Financial Associates’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
$348K Sell
4,776
-4,145
-46% -$302K 0.02% 296
2021
Q3
$623K Buy
8,921
+301
+3% +$21K 0.03% 235
2021
Q2
$593K Sell
8,620
-1,052
-11% -$72.4K 0.03% 234
2021
Q1
$625K Sell
9,672
-329
-3% -$21.3K 0.04% 222
2020
Q4
$582K Sell
10,001
-951
-9% -$55.3K 0.04% 222
2020
Q3
$692K Buy
10,952
+321
+3% +$20.3K 0.05% 183
2020
Q2
$818K Sell
10,631
-3,535
-25% -$272K 0.07% 161
2020
Q1
$1.06M Buy
14,166
+10,750
+315% +$804K 0.1% 124
2019
Q4
$222K Sell
3,416
-2,304
-40% -$150K 0.02% 337
2019
Q3
$362K Buy
5,720
+1,774
+45% +$112K 0.03% 264
2019
Q2
$266K Buy
3,946
+724
+22% +$48.8K 0.02% 305
2019
Q1
$209K Buy
3,222
+321
+11% +$20.8K 0.02% 317
2018
Q4
$198K Buy
2,901
+16
+0.6% +$1.09K 0.02% 266
2018
Q3
$222K Sell
2,885
-309
-10% -$23.8K 0.02% 267
2018
Q2
$226K Buy
3,194
+631
+25% +$44.6K 0.02% 260
2018
Q1
$193K Buy
2,563
+18
+0.7% +$1.36K 0.02% 274
2017
Q4
$182K Sell
2,545
-1,964
-44% -$140K 0.02% 281
2017
Q3
$376K Sell
4,509
-150
-3% -$12.5K 0.04% 187
2017
Q2
$329K Buy
4,659
+54
+1% +$3.81K 0.04% 211
2017
Q1
$312K Sell
4,605
-500
-10% -$33.9K 0.04% 209
2016
Q4
$365K Sell
5,105
-135
-3% -$9.65K 0.05% 171
2016
Q3
$414K Buy
5,240
+365
+7% +$28.8K 0.06% 160
2016
Q2
$406K Buy
4,875
+60
+1% +$5K 0.07% 153
2016
Q1
$442K Buy
4,815
+325
+7% +$29.8K 0.08% 142
2015
Q4
$454K Sell
4,490
-173
-4% -$17.5K 0.09% 127
2015
Q3
$474K Buy
4,663
+329
+8% +$33.4K 0.11% 120
2015
Q2
$507K Buy
4,334
+2,988
+222% +$350K 0.11% 113
2015
Q1
$132K Buy
1,346
+47
+4% +$4.61K 0.06% 170
2014
Q4
$128K Sell
1,299
-2,535
-66% -$250K 0.08% 145
2014
Q3
$414K Buy
3,834
+708
+23% +$76.5K 0.13% 103
2014
Q2
$259K Buy
3,126
+150
+5% +$12.4K 0.07% 144
2014
Q1
$211K Buy
2,976
+90
+3% +$6.38K 0.07% 146
2013
Q4
$216K Buy
2,886
+135
+5% +$10.1K 0.08% 138
2013
Q3
$172K Buy
2,751
+411
+18% +$25.7K 0.06% 150
2013
Q2
$119K Buy
+2,340
New +$119K 0.06% 148